VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018)
VitaNova Life Sciences' (VNOV) quarterly Total Non-Current Liabilities came in at $12600.0 in Q3 2018, up 125.0% on a QoQ basis from $5600.0 in Q2 2018.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Total Non-Current Liabilities (2017 - 2018) Analysis & Trends
VitaNova Life Sciences has disclosed Total Non-Current Liabilities across 2 years of filings, most recently posting $12600.0 for Q3 2018.
- Total Non-Current Liabilities for Q3 2018 came in at $12600.0, changed N/A year-over-year; the trailing twelve-month figure through Jul 2018 was $12600.0 (changed N/A YoY), and the FY2018 annual result was $5600.0, down 51.72% from the prior year.
- Total Non-Current Liabilities for Q3 2018 stood at $12600.0, up from $5600.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $12600.0 in Q3 2018 and bottomed at $5600.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 13.69 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 1.41 Bn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 6.90 Bn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 6.02 Bn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 2.38 Bn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 2.41 Bn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 248.34 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 2.11 Bn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | 1.79 Bn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2018 | 12,600.00 |
| Apr 30, 2018 | 5,600.00 |
| Jan 31, 2018 | 5,600.00 |
| Oct 31, 2017 | 5,600.00 |
| Apr 30, 2017 | 11,600.00 |